FORMULATION OF PGV-0 A NEW ANTIINFLAMMATORY AGENT AS A TABLET DOSAGE FORM

R. A. Oetari; Sardjiman .; Tedjo Yuwono; Achmad Fudholi

doi:10.14499/indonesianjpharm0iss0pp160-168

FORMULATION OF PGV-0 A NEW ANTIINFLAMMATORY AGENT AS A TABLET DOSAGE FORM

R. A. Oetari, Sardjiman ., Tedjo Yuwono, Achmad Fudholi

Abstract

The specific objective of this study is to get the best formulation for PGV-0 as a tablet dosage form. By optimation of formulation a more potent and safe antiinflamatory drug could be obtained. This study was started with determination of physical properties which included: appearance, particle size, partition coefficient, and hygroscopicity. In the formulation of PGV-0 6 formulas were chosen with amylum and lactose as fillers, tween 80 as surfactant, solutiogelatine and solutio PVP as binding agent and talc and Mg stearate as lubricants. From these six formulas chosen physical properties of the granules and tablets were determined. PGV-0 powder was not free flowing and has bad compressibility. PGV-0 could not be proccesed by direct compression but should be formulated by wet granulation method. The best formula found was formula V which used solutio PVP 2 % as binding agent and tween 80 0,25 % as wetting agent.

Key words: PGV-0, antiinflammation, formulation of tablet dosage form.

Full Text:

Untitled

References

Anonim, 1979, Farmakope Indonesia, Ed. 3, Departemen Kesehatan RI, Jakrata.

Anonim, 2001a, Uji Toksisitas Senyawa PGV-0, PGV-1 dan HGV-1, Laporan Penelitian

MOLNAS.

Anonim, 2001b, Sintesis dan efek antiinflamasi senyawa turunan siklovalon, Laporan Penelitian MOLNAS.

Ansel,H.C.,Popovich, N.G dan Allen,L.V.,Jr .,1995, Pharmaceutical Dosage Forms and Drug Delivery Systems, 6th Ed.,Williams and Wilkins, USA caracteristiques des formes

orales solides, Sci.Techn.Pharm, 5, 10,545 - 555

Carstensen, J.T., 1977, Pharmaceutics of Solids and Solid Dosage Forms, John Wiley & Sons, New York, 11-15, 237, 238, 248.

Fudholi, A., 1996, Pengaruh Bahan Pengikat Terhadap Karakteristik Granul dan Sifat

FisisTablet, Majalah Farmasi Indonesia, Vol.7., No. 1

Lieberman, H.A. and Lachman, L., 1980, Pharmaceutical Dosage Forms, vol I, Marcel

DekkerInc, New York, Basel.

Martin, A., Bustamate, P., dan Chun, A.H.C., 1993, Physical Pharmacy: Physical Chemical

Principles in the Pharmaceutical Sciences, 4th. Ed., Lea & Febiger, Philadelphia, 237-239.

Oetari, RA., Sardjiman, Tedjo Yuwono, Lukman Hakim, 2001, Upaya Peningkatan Absorpsi

Senyawa Baru Antiinflamasi PGV-0, Laporan Penelitian Hibah Bersaing IX/I Perguruan TinggiTahun Anggaran 2001

Richards, J.H., 1994, dalam Pharmaceutics The Science of Dosage Form Design, ELBS, Hongkong, 62-80.

Rubinstein, M.H., 1994, dalam Pharmaceutics The Science of Dosage Form Design, ELBS,Hongkong, 304-321.

Sardjiman, Reksohadiprodjo, M.S., Hakim, L., van der Goot, H., Timmerman, H., 1997,1,5-Diphenyl-1,4-pentadien-3-dione and cyclic analogues as antioxydative agents. Synthesis and structure-activity relationships, Eur.J.Med. Chem., 32, 625-630

Shargel, L. dan Yu, A.B.C., 1993, Applied Biopharmaceutics and pharmacokinetic, 3rdEd., Appleton and Lange, Eastwalk, Connecticut, 134-167.

Soebagyo, S., 1994, Amilum Termodifikasi sebagai Bahan Pemolong Tablet Cetak Langsung

Parasetamol, Majalah Farmasi Indonesia, Vol. 5, No. 4, 147-153.

DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp160-168